Ulland Investment Advisors LLC Has $1.10 Million Stake in Synopsys, Inc. $SNPS

Ulland Investment Advisors LLC raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 3,441.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,231 shares of the semiconductor company’s stock after purchasing an additional 2,168 shares during the quarter. Synopsys accounts for about 0.8% of Ulland Investment Advisors LLC’s investment portfolio, making the stock its 27th biggest position. Ulland Investment Advisors LLC’s holdings in Synopsys were worth $1,101,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. Brighton Jones LLC increased its stake in Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after acquiring an additional 50 shares during the period. Integrated Wealth Concepts LLC lifted its position in shares of Synopsys by 11.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after acquiring an additional 79 shares during the period. NewEdge Advisors LLC grew its holdings in shares of Synopsys by 15.1% during the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after purchasing an additional 395 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Synopsys during the second quarter valued at approximately $6,564,000. Finally, Allworth Financial LP increased its position in shares of Synopsys by 182.1% during the second quarter. Allworth Financial LP now owns 7,050 shares of the semiconductor company’s stock valued at $3,615,000 after purchasing an additional 4,551 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Morgan Stanley reaffirmed an “equal weight” rating and issued a $480.00 target price (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. KeyCorp boosted their price target on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Piper Sandler reduced their price objective on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a report on Thursday, February 26th. Finally, Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and decreased their target price for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $531.00.

Insider Transactions at Synopsys

In other Synopsys news, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last quarter. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Price Performance

SNPS stock traded down $6.85 during trading on Friday, hitting $411.87. The company had a trading volume of 325,023 shares, compared to its average volume of 2,266,479. The company has a fifty day moving average price of $463.28 and a two-hundred day moving average price of $465.85. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a market cap of $78.90 billion, a P/E ratio of 63.96, a P/E/G ratio of 3.53 and a beta of 1.15. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.39 billion. During the same period in the prior year, the company posted $3.03 earnings per share. The business’s revenue for the quarter was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.